No Data
No Data
Hong Kong stock concept tracking | Medical devices trade-in program attracts institutional attention, clear trend of market recovery.
"Trade-in" is accelerating in the field of medical devices, and various provinces are intensively issuing "feasibility announcements", "project approval announcements" and "tender procurement notices", injecting a dose of "cardiotonic" into the market.
There is no limit on price fluctuation, new stocks are being speculated! The pioneer of ultrasound submits an application for registration on the gem.
Cumulative dividends exceed 0.3 billion in 4 years.
Market Participants Recognise Shanghai INT Medical Instruments Co., Ltd.'s (HKG:1501) Earnings
INT MEDICAL: Interim Report 2024
Shanghai INT Medical Instruments Posts Higher H1 Profit
Eitai Medical (01501) releases interim results, with a net profit of 0.101 billion yuan attributable to equity shareholders, a 24.89% increase year-on-year.
Erae Medical (01501) has released its interim performance for the six-month period ending on June 30, 2024...
No Data
No Data